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Abstract: Flaviviruses, such as dengue virus and West Nile virus, are enveloped viruses 
that infect cells through receptor-mediated endocytosis and fusion from within acidic 
endosomes. The cell entry process of flaviviruses is mediated by the viral E glycoprotein. 
This short review will address recent advances in the understanding of flavivirus cell entry 
with specific emphasis on the recent study of Zaitseva and coworkers, indicating that 
anionic lipids might play a crucial role in the fusion process of dengue virus [1].  
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1. Introduction  
Dengue virus (DENV) is a major emerging arthopod-borne pathogen causing a significant burden 
of disease in tropical and subtropical areas of the world [2,3]. DENV is a positive-sense RNA virus, 
belonging to the genus “Flaviviruses” of the family Flaviviridae [4]. The flavivirus genus comprises 
more than 70 viruses including, besides DENV, a number of other important human pathogens such as 
West Nile virus (WNV), tick-borne encephalitis virus (TBEV), Japanese encephalitis virus (JEV), and 
yellow fever virus (YFV). Flaviviruses are enveloped viruses, which enter their host cells through a 
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process of receptor-mediated endocytosis and subsequent fusion from within the endosomal cell 
compartment. This fusion process is triggered by the mildly acidic pH within the lumen of the 
endosome [4]. In this short review, new insights in flavivirus cell entry and membrane fusion will be 
discussed. We will emphasize specifically the role of target membrane lipids in the membrane fusion 
activity of DENV [1].  
2. Structure of Flaviviruses 
Flaviviruses are small, icosahedral viruses. The viral genome consists of a single-stranded, positive-
sense RNA molecule which is complexed to multiple copies of the capsid protein [5]. The 
nucleocapsid is surrounded by a host-derived lipid membrane, in which two transmembrane proteins 
are inserted, the major envelope glycoprotein E (53 kDa) and the membrane protein M (8 kDa). The M 
protein is a small proteolytic fragment of its precursor form prM (approximately 21 kDa) and is 
anchored into the viral membrane by two transmembrane helices [6,7]. In mature virions, the E 
glycoproteins are arranged in 90 homodimers with sets of three E head-to-tail homodimers that lie in 
30 rafts and form a herringbone pattern [6]. The E ectodomain has three structurally distinct domains 
(DI, DII, DIII) that are connected by flexible hinge regions [8]. Neither E nor M interacts with the 
nucleocapsid in mature virions [9]. In infected cells, virions are initially assembled in an immature 
form with a distinct structural organization. In these particles, the E glycoprotein is associated with the 
glycoprotein prM and three of these heterodimers form one viral spike [6,10]. Virus particle 
maturation occurs during viral egress.  
3. Flavivirus Cell Entry 
3.1 Receptor Binding 
The first step in the infectious cell entry pathway of flaviviruses involves binding of the E 
glycoprotein to a cellular receptor. Flaviviruses must recognize a ubiquitous cell surface molecule or 
utilize multiple receptors for cell entry as flavivirus infection has been observed in a variety of cell 
lines derived from different host species [11]. In recent years several attachment factors have been 
identified, indicating that flaviviruses may use multiple receptors for cell entry.  
Negatively charged glycoaminoglycans, such as heparan sulfate, which are abundantly expressed on 
numerous cell types, are utilized as low-affinity attachment factors by several flaviviruses [12-18]. 
These interactions serve to concentrate the virus at the cell surface and are mediated by domain DIII of 
the E glycoprotein. Multiple other attachment factors have been identified for DENV in mammalian 
cells including heat-shock proteins 90 and 70 [19], neolactotetraosylceramide [20], CD14 [21], 
GRP78/BiP [22], 37-kDa/67-kDa laminin [23], and C-type lectins such as DC-SIGN (dendritic   
cell-specific intracellular adhesion molecule-3 (ICAM3)-grabbing non-integrin) [24-26], the mannose 
receptor [27], and C-type lectin domain family 5, member A (CLEC5, MDL-1) [28]. In mosquito cells, 
DENV has been shown to interact with heat-shock protein 70, R80, R67 and a 45-kDa protein 
[19,29,30]. Crystallographic studies on DENV-DC-SIGN complexes revealed that interaction with 
DC-SIGN is preferentially mediated through the carbohydrate moiety at Asn67 in EDII [31]. WNV has 
also been shown to interact with DC-SIGN and DC-SIGNR in dendritic cells [32,33]. Furthermore, Viruses 2011, 3                                       
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WNV, JEV, and DENV, albeit to a lesser extent, have been documented to bind to αvβ3 integrins 
expressed on mammalian cells, mediated through interaction with EDIII [34,35]. On the other hand, 
entry of WNV into embryonic mouse fibroblasts and hamster melanoma is independent of   
αvβ3 integrin binding, suggesting that receptor molecule usage is strain-specific and/or cell   
type-dependent [36]. 
3.2 Entry of Flavivirus Particles into Cells  
Flaviviruses enter cells through clathrin-mediated endocytosis. Single-particle tracking analysis of 
DENV particles in living cells revealed that DENV particles diffuse along the cell surface towards a 
pre-existing clathrin-coated pit [37]. This implies that virions roll over distinct attachment factors 
untill they bind to the entry receptor localized to clathrin hotspots at the cell surface or that the initially 
formed virus-receptor complex is transported towards a pre-existing clathrin-coated pit. Subsequently, 
the clathrin-coated pit evolves and the invagination in the plasma membrane is closed by membrane 
scission mediated by dynamin to form a clathrin-coated vesicle. The clathrin-coated vesicle is 
transported away from the plasma membrane after which the clathrin coat is released from the vesicle. 
Real-time microscopy analysis showed that DENV particles remain associated with clathrin for 
approximately 80 seconds [37]. Earlier evidence that flaviviruses utilize clathrin-mediated endocytosis 
for cell entry was obtained by ultrastructural studies showing the presence of Kunjin and YFV in 
coated pits [38,39]. Furthermore, inhibition of WNV infection was observed in cells treated with 
chemical inhibitors like chlorpromazine [40] that prevent clathrin-coated pit formation and in cells 
expressing dominant-negative mutants of Eps15, a protein which is involved in clathrin-coated pit 
formation [41,42]. The route of flavivirus cell entry appears to be dependent on the virus strain and the 
cell type as a recent report documented entry of DENV in mammalian cells independent of clathrin, 
caveolae and lipid rafts [43].  
After clathrin-mediated uptake, the endocytic vesicle carrying the virus is delivered to early 
endosomes. Internalization of flavivirus particles occurs rapidly as a large fraction of WNV and 
DENV particles were observed to localize to early endosomes within five minutes post-entry [37,41]. 
Thereafter, the early endosome carrying the virus matures into a late endosome. For DENV, membrane 
fusion has been observed to occur primarily from within late endosomal compartments [37]. 
Membrane fusion was detected on average at 10-13 minutes after initiation of infection. It is important 
to note that the subcellular compartment from which membrane fusion occurs is most likely dependent 
on the pH-dependent membrane fusion properties of the virus and may therefore vary between 
individual DENV strains [37,44]. 
4. Molecular Mechanism of Membrane Fusion 
4.1 Low-pH-induced Conformational Changes in the E Glycoprotein 
The low-pH environment within endosomes triggers a series of molecular events within the E 
glycoprotein leading to membrane fusion of the viral membrane with the endosomal membrane and 
subsequent release of the nucleocapsid into the cell cytosol. Protonation of one or more histidine 
residues has been postulated to trigger the conformational changes of the E protein [45,46]. Indeed, Viruses 2011, 3                                       
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studies on TBEV identified two conserved histidines (at position 146 and 323) that may act as pH 
sensors and destabilize the DI-DIII interface [47]. On the other hand, site-specific mutagenesis studies 
on WNV revealed that histidine residues are not required for the initiation of the conformational 
changes required for membrane fusion [48].  
The conformational changes of the E glycoprotein that occur during the membrane fusion process 
of flaviviruses have been studied extensively [45,46,49]. The initial step in membrane fusion involves 
protonation-dependent disruption of the E protein rafts at the viral surface, including dissociation of E 
homodimers into monomers. This leads to the outward projection of DII and exposure of the fusion 
loop at the distal tip of DII to the target membrane. Subsequently, the E proteins insert their fusion 
loops into the outer leaflet of the membrane and three copies of E interact with one another via their 
fusion loops or DII domains to form an unstable trimer. The E trimers stabilize through additional 
interactions between the DI domains of the three E proteins [50]. Next, DIII is believed to fold back 
against the trimer to form a hairpin-like configuration. The energy released by these conformational 
changes induces the formation of a hemifusion intermediate, in which the monolayers of the 
interacting membranes are merged while the inner membranes are still intact. Finally, a fusion pore is 
formed and after enlargement of the pore, the nucleocapsid is released into the cytosol.  
4.2 Role of Cholesterol in Flavivirus Membrane Fusion 
Besides the mildly acidic endosomal pH, it is the composition of the target membrane that plays an 
important role in the membrane fusion process of flaviviruses. In vitro studies have revealed that 
flaviviruses such as TBEV and WNV have the capacity to fuse with artificial receptor-free lipid 
membranes (liposomes) consisting of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) at 
low pH, albeit with low efficiency [51-53]. Addition of cholesterol to target membranes was found to 
have a strong promoting effect on the membrane fusion capacity of TBEV and WNV [51-54]. 
Subsequent virus-liposome coflotation studies have indicated that cholesterol stimulates the low-pH-
triggered interaction of the E glycoprotein with lipid membranes [54,55]. The 3-hydroxyl group of 
cholesterol is important for this function [54]. Interestingly, and in contrast to alphaviruses, the E 
glycoprotein does not appear to directly interact with cholesterol in the target membrane [55]. These 
observations suggest that the promoting effect of cholesterol on membrane fusion is due to an overall 
change in the fluidity or physico-chemical properties of the target membrane. Although most studies 
were performed with TBEV and WNV, several recent studies show that DENV also has the capacity to 
interact and fuse with artifical membranes consisting of PC, PE, sphingolipids and cholesterol [56-58]. 
Cholesterol also plays an important role in facilitating efficient cell entry of flaviviruses as viral 
infectivity was found to be significantly impaired in cholesterol-depleted cells [36,59-61]. 
4.3 Role of Negatively Charged Lipids in Dengue Virus Membrane Fusion 
A recent study from Zaitseva and coworkers showed that DENV may utilize anionic lipids as a 
cofactor during the low-pH-driven membrane fusion process of the virus [1]. The investigation, by 
these authors, of the lipid dependence of DENV membrane fusion was triggered by the observation 
that DENV does not fuse with the plasma membrane of mammalian cells under low-pH conditions 
whereas efficient fusion occurred with the plasma membrane of insect cells. A difference between Viruses 2011, 3                                       
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these cell types is that insect cells have an unusually high concentration of anionic lipids in their 
plasma membrane. Accordingly, the authors found that addition of anionic lipids, such as 
bis(monoacylglycero)phosphate (BMP) and phosphatidylserine (PS), to the plasma membrane of 
mammalian cells facilitates low-pH-induced plasma membrane fusion of DENV. The role of anionic 
lipids in DENV membrane fusion was confirmed by in vitro virus-liposome fusion measurements, in 
which efficient membrane fusion was only observed using target membranes consisting of PC (70 
mol%) and BMP or PS or phosphatidylglycerol (PG). Furthermore, anionic lipids were observed to act 
downstream of the formation of a restricted hemifusion intermediate and likely promote the opening of 
the fusion pore. Interestingly, in mammalian cells, anionic lipids are enriched in late endosomal 
compartments, thus this observation may also explain why DENV fusion is primarily initiated from 
within these compartments [37].  
While the study of Zaitseva et al. is elegant and may explain a number of the characteristics of 
DENV cell entry, a word of caution seems justified. In earlier studies, negatively charged 
phospholipids have been observed to promote a number of viral membrane fusion reactions. First, PS 
has been suggested to serve as a receptor in cell entry of vesicular stomatitis virus [62], but more 
recent studies have challenged this view [63]. Furthermore, influenza virus was found to fuse quite 
efficiently with liposomes consisting of the anionic lipid cardiolipin in a low-pH-dependent 
manner [64]. However, subsequent detailed characterization of this fusion reaction revealed that it 
does not reflect the physiological fusion process of the virus. Specifically, the well-documented 
conformational change in the viral hemagglutinin (HA) turned out not to be involved [65]. Indeed, 
influenza virus pre-exposed to low pH in the absence of target membranes remained fusion-active with 
cardiolipin target liposomes [65,66], while such a low-pH pretreatment is known to result in a rapid 
and irreversible loss of fusion capacity—and infectivity—of the virus [66]. It thus appears that anionic 
lipids have a tendency to promote membrane fusion of enveloped viruses (and, for that matter, other 
biological membranes as well [67]), in a general, sometimes nonphysiological, manner [68]. The fact 
that, in the study of Zaitseva et al., several structurally different negatively charged phospholipids 
stimulate fusion of DENV, including lipids—such as phosphatidylglycerol (PG)—that are not present 
in the natural endosomal target membrane of the virus does not seem to support the notion of a highly 
specific cofactor role of these lipids in the process [1]. On the other hand, the experiments of Zaitseva 
et al. are well-designed and convincing. In particular, the observation that the anionic lipids act at a 
stage downstream of the formation of the hemifusion intermediate [1] is reassuring, as this localizes 
the role of these lipids to the cytoplasmic half of the endosomal target membrane, which is the leaflet 
where negatively charged phospholipids are primarily located. Further studies will be required to 
elucidate whether indeed anionic phospholipids represent a necessary and sufficient factor involved in 
infectious DENV fusion from within acidic endosomes.  
5. Particle Maturation Status and Infectivity  
Flavivirus-infected cells are known to secrete a mixture of mature, immature and partially mature 
particles. The prM quantity appears to be different between flaviviruses; whereas high numbers of 
prM-containing particles have been described for WNV and DENV [53,69-75], low numbers were 
observed for TBEV [76]. A recent study showed that as much as 40% of all extracellular DENV Viruses 2011, 3                                       
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particles derived from C6/36 mosquito cells are partially immature [77]. Overall, this demonstrates 
that flavivirus maturation during virus egress is rather inefficient. Upon assembly of immature virions 
in the ER, all virus particles are transported to the Golgi apparatus [78-82]. Within the mildly acidic 
environment of the Golgi, the virion undergoes a global conformational change leading to dissociation 
of E/prM heterodimers and formation of 90 homodimers [58,76,83]. This conformational change 
allows the host protease furin to cleave prM to M and a “pr” peptide [58,76,83,84]. The pr peptide 
dissociates from the particle upon release of the virion to the extracellular milieu [58,76,84,85]. It 
appears that furin processing of prM is rather inefficient and flavivirus particles that contain uncleaved 
prM proteins will, after the release of the virion to the extracellular milieu, reorganize back to form 
prM/E heterodimers at the viral surface.  
Numerous functional studies have shown that fully immature particles are noninfectious   
[53,58,74-76,83,86]. However, we and others recently demonstrated that fully immature particles can 
be rendered infectious by antibodies [87,88]. We observed that the lack of infectivity of fully immature 
particles was found to be related to inefficient binding to the cell surface [88]. Upon cell entry, 
immature virions are efficiently processed by furin, the pr peptide presumably being released at the 
low-pH environment of endosomes [85]. Whereas proteolytic cleavage of prM is a prerequisite for 
viral infectivity, multiple studies have shown that complete cleavage is not required for infectivity 
[74,75,89,90]. In partially mature particles, the mature aspect of the virion is most likely responsible 
for virus cell binding and entry after which the processing of prM may occur within the target cell and 
membrane fusion may be initiated. The threshold for viral infectivity in relation to the number of prM 
proteins present at the viral surface is as yet not understood. 
6. Concluding Remarks 
In recent years, our knowledge on the cell entry properties and membrane fusion activity of 
flaviviruses has improved significantly. Microscopic analysis of virus-infected cells has taught us how 
viruses hijack cellular pathways to deposit their genome into the host cell cytosol. Also, biochemical 
and structural approaches have identified important steps in the membrane fusion process of 
flaviviruses. The observation that viral infectivity is dependent on the maturation status of the particle 
is interesting and adds yet another layer of complexity to flavivirus cell entry. Future studies should be 
directed at a further dissection of the dynamics of flavivirus entry into human target cells and a 
detailed understanding of, not only the conformational changes of the E glycoprotein during membrane 
fusion, but also the role of target membrane lipids in the fusion process. Furthermore, given the 
substantial levels of prM in wt DENV, it will be crucial to gain more insight in the role of immature or 
partially immature virions in viral infectivity. A detailed understanding of the cell entry and membrane 
fusion process of flaviviruses is important and will facilitate the generation of novel antiviral drugs 
that prevent early steps of infection.   
Acknowledgements 
This work was supported by the Pediatric Dengue Vaccine Initiative, and by the Dutch Organization 
for Scientific research (NWO-ALW).  Viruses 2011, 3                                       
 
 
166
References and notes 
1.  Zaitseva, E.; Yang, S.T.; Melikov, K.; Pourmal, S.; Chernomordik, L.V. Dengue virus ensures its 
fusion in late endosomes using compartment-specific lipids. PLoS. Pathog. 2010, 6, e1001131. 
2.  World Health Organization. Dengue fact sheet, 2009. Available online: 
http://www.who.int/mediacentre/factsheets/fs117/en/ (assessed Jan 2011).  
3.  Gubler, D.J. Dengue/dengue haemorrhagic fever: history and current status. Novartis. Found. 
Symp. 2006, 277, 3-16. 
4.  Burke, D.S.; Monath, T.P. Flaviviruses. in Fields Virology; Knipe, D.M., Howley, P.M, Eds.; 
Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2001; Volume 1; pp 1043-1125. 
5.  Lindenbach, B.D.; Rice, C.M. Molecular biology of flaviviruses. Adv. Virus Res. 2003, 59, 23-61. 
6.  Kuhn, R.J.; Zhang, W.; Rossmann, M.G.; Pletnev, S.V.; Corver, J.; Lenches, E.; Jones, C.T.; 
Mukhopadhyay, S.; Chipman, P.R.; Strauss, E.G.; Baker, T.S.; Strauss, J.H. Structure of dengue 
virus: implications for flavivirus organization, maturation, and fusion. Cell 2002, 108, 717-725. 
7.  Zhang, W.; Chipman, P.R.; Corver, J.; Johnson, P.R.; Zhang, Y.; Mukhopadhyay, S.; Baker, T.S.; 
Strauss, J.H.; Rossmann, M.G.; Kuhn, R.J. Visualization of membrane protein domains by cryo-
electron microscopy of dengue virus. Nat. Struct. Biol. 2003, 10, 907-912. 
8.  Rey, F.A.; Heinz, F.X.; Mandl, C.; Kunz, C.; Harrison, S.C. The envelope glycoprotein from tick-
borne encephalitis virus at 2 Å resolution. Nature 1995, 375, 291-298. 
9.  Mukhopadhyay, S.; Kuhn, R.J.; Rossmann, M.G. A structural perspective of the flavivirus life 
cycle. Nat. Rev. Microbiol. 2005, 3, 13-22. 
10.  Zhang, Y.; Corver, J.; Chipman, P.R.; Zhang, W.; Pletnev, S.V.; Sedlak, D.; Baker, T.S.; Strauss, 
J.H.; Kuhn, R.J.; Rossmann, M.G. Structures of immature flavivirus particles. EMBO J. 2003, 22, 
2604-2613. 
11.  Rodenhuis-Zybert, I.A.; Wilschut, J.; Smit, J.M. Dengue virus life cycle: viral and host factors 
modulating infectivity. Cell Mol. Life Sci. 2010, 67, 2773-2786. 
12.  Chen, Y.; Maguire, T.; Hileman, R.E.; Fromm, J.R.; Esko, J.D.; Linhardt, R.J.; Marks, R.M. 
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate.   
Nat. Med. 1997, 3, 866-871. 
13.  Germi, R.; Crance, J.M.; Garin, D.; Guimet, J.; Lortat-Jacob, H.; Ruigrok, R.W.; Zarski, J.P.; 
Drouet, E. Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever 
virus. Virology 2002, 292, 162-168. 
14.  Hilgard, P.; Stockert, R. Heparan sulfate proteoglycans initiate dengue virus infection of 
hepatocytes. Hepatology 2000, 32, 1069-1077. 
15.  Chen, H.L.; Her, S.Y.; Huang, K.C.; Cheng, H.T.; Wu, C.W.; Wu, S.C.; Cheng, J.W. 
Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein. 
Biopolymers 2010, 94, 331-338. 
16.  Kozlovskaya, L.I.; Osolodkin, D.I.; Shevtsova, A.S.; Romanova, L.I.; Rogova, Y.V.; Dzhivanian, 
T.I.; Lyapustin, V.N.; Pivanova, G.P.; Gmyl, A.P.; Palyulin, V.A.; Karganova, G.G. GAG-
binding variants of tick-borne encephalitis virus. Virology 2010, 398, 262-272. Viruses 2011, 3                                       
 
 
167
17.  Lee, E.; Lobigs, M. E protein domain III determinants of yellow fever virus 17D vaccine strain 
enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence. J. Virol. 
2008, 82, 6024-6033. 
18.  Mandl, C.W.; Kroschewski, H.; Allison, S.L.; Kofler, R.; Holzmann, H.; Meixner, T.; Heinz, F.X. 
Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple 
heparan sulfate binding sites in the envelope protein and attenuation in vivo. J. Virol. 2001, 75, 
5627-5637. 
19.  Reyes-Del, V.J.; Chavez-Salinas, S.; Medina, F.; del Angel, R.M. Heat shock protein 90 and heat 
shock protein 70 are components of dengue virus receptor complex in human cells. J. Virol. 2005, 
79, 4557-4567. 
20.  Aoki, C.; Hidari, K.I.; Itonori, S.; Yamada, A.; Takahashi, N.; Kasama, T.; Hasebe, F.; Islam, 
M.A.; Hatano, K.; Matsuoka, K.; et. al. Identification and characterization of carbohydrate 
molecules in mammalian cells recognized by dengue virus type 2. J. Biochem.  2006,  139,  
607-614. 
21.  Chen, Y.C.; Wang, S.Y.; King, C.C. Bacterial lipopolysaccharide inhibits dengue virus infection 
of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent 
mechanism. J. Virol. 1999, 73, 2650-2657. 
22.  Jindadamrongwech, S.; Thepparit, C.; Smith, D.R. Identification of GRP 78 (BiP) as a liver cell 
expressed receptor element for dengue virus serotype 2. Arch. Virol. 2004, 149, 915-927. 
23.  Thepparit, C.; Smith, D.R. Serotype-specific entry of dengue virus into liver cells: identification 
of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 
receptor. J. Virol. 2004, 78, 12647-12656. 
24.  Lozach, P.Y.; Burleigh, L.; Staropoli, I.; Navarro-Sanchez, E.; Harriague, J.; Virelizier, J.L.; Rey, 
F.A.; Despres, P.; Renzana-Seisdedos, F.; Amara, A. Dendritic cell-specific intercellular adhesion 
molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is 
independent of DC-SIGN internalization signals. J. Biol. Chem. 2005, 280, 23698-23708. 
25.  Navarro-Sanchez, E.; Altmeyer, R.; Amara, A.; Schwartz, O.; Fieschi, F.; Virelizier, J.L.; 
renzana-Seisdedos, F.; Despres, P. Dendritic-cell-specific ICAM3-grabbing non-integrin is 
essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue 
viruses. EMBO Rep. 2003, 4, 723-728. 
26.  Tassaneetrithep, B.; Burgess, T.H.; Granelli-Piperno, A.; Trumpfheller, C.; Finke, J.; Sun, W.; 
Eller, M.A.; Pattanapanyasat, K.; Sarasombath, S.; Birx, D.L.; et al. DC-SIGN (CD209) mediates 
dengue virus infection of human dendritic cells. J. Exp. Med. 2003, 197, 823-829. 
27.  Miller, J.L.; de Wet, B.J.; Martinez-Pomares, L.; Radcliffe, C.M.; Dwek, R.A.; Rudd, P.M.; 
Gordon, S. The mannose receptor mediates dengue virus infection of macrophages. PLoS. Pathog. 
2008, 4, e17. 
28.  Chen, S.T.; Lin, Y.L.; Huang, M.T.; Wu, M.F.; Cheng, S.C.; Lei, H.Y.; Lee, C.K.; Chiou, T.W.; 
Wong, C.H.; Hsieh, S.L. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 
2008, 453, 672-676. 
29.  Mercado-Curiel, R.F.; Esquinca-Aviles, H.A.; Tovar, R.; az-Badillo, A.; Camacho-Nuez, M.; 
Munoz, M.L. The four serotypes of dengue recognize the same putative receptors in Aedes 
aegypti midgut and Ae. albopictus cells. BMC. Microbiol. 2006, 6, 85. Viruses 2011, 3                                       
 
 
168
30.  Yazi, M.M.; Salas-Benito, J.S.; Lanz-Mendoza, H.; Hernandez-Martinez, S.; del Angel, R.M.   
A putative receptor for dengue virus in mosquito tissues: localization of a 45-kDa glycoprotein. 
Am. J. Trop. Med. Hyg. 2002, 67, 76-84. 
31.  Pokidysheva, E.; Zhang, Y.; Battisti, A.J.; Bator-Kelly, C.M.; Chipman, P.R.; Xiao, C.; Gregorio, 
G.G.; Hendrickson, W.A.; Kuhn, R.J.; Rossmann, M.G. Cryo-EM reconstruction of dengue virus 
in complex with the carbohydrate recognition domain of DC-SIGN. Cell 2006, 124, 485-493. 
32.  Davis, C.W.; Nguyen, H.Y.; Hanna, S.L.; Sanchez, M.D.; Doms, R.W.; Pierson, T.C. West Nile 
virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J. 
Virol. 2006, 80, 1290-1301. 
33.  Davis, C.W.; Mattei, L.M.; Nguyen, H.Y.; nsarah-Sobrinho, C.; Doms, R.W.; Pierson, T.C. The 
location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 
(dendritic cell-specific ICAM-3 grabbing nonintegrin). J. Biol. Chem. 2006, 281, 37183-37194. 
34.  Chu, J.J.; Ng, M.L. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus 
entry into cells. J. Biol. Chem. 2004, 279, 54533-54541. 
35.  Lee, J.W.; Chu, J.J.; Ng, M.L. Quantifying the specific binding between West Nile virus envelope 
domain III protein and the cellular receptor alphaVbeta3 integrin. J. Biol. Chem.  2006,  281,  
1352-1360. 
36.  Medigeshi, G.R.; Hirsch, A.J.; Streblow, D.N.; Nikolich-Zugich, J.; Nelson, J.A. West Nile virus 
entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 
integrin. J. Virol. 2008, 82, 5212-5219. 
37.  van der Schaar, H.M.; Rust, M.J.; Chen, C.; van der Ende.-Metselaar; Wilschut, J.; Zhuang, X.; 
Smit, J.M. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living 
cells. PLoS. Pathog. 2008, 4, e1000244. 
38.  Ishak, R.; Tovey, D.G.; Howard, C.R. Morphogenesis of yellow fever virus 17D in infected cell 
cultures. J. Gen. Virol. 1988, 69, 325-335. 
39.  Ng, M.L.; Lau, L.C. Possible involvement of receptors in the entry of Kunjin virus into Vero 
cells. Arch. Virol. 1988, 100, 199-211. 
40.  Nawa, M.; Takasaki, T.; Yamada, K.; Kurane, I.; Akatsuka, T. Interference in Japanese 
encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine. J. Gen. 
Virol. 2003, 84, 1737-1741. 
41.  Chu, J.J.; Ng, M.L. Infectious entry of West Nile virus occurs through a clathrin-mediated 
endocytic pathway. J. Virol. 2004, 78, 10543-10555. 
42.  Chu, J.J.; Leong, P.W.; Ng, M.L. Analysis of the endocytic pathway mediating the infectious 
entry of mosquito-borne flavivirus West Nile into Aedes albopictus mosquito (C6/36) cells. 
Virology 2006, 349, 463-475. 
43.  Acosta, E.G.; Castilla, V.; Damonte, E.B. Alternative infectious entry pathways for dengue virus 
serotypes into mammalian cells. Cell Microbiol. 2009, 11, 1533-1549. 
44.  Krishnan, M.N.; Sukumaran, B.; Pal, U.; Agaisse, H.; Murray, J.L.; Hodge, T.W.; Fikrig, E. Rab 5 
is required for the cellular entry of dengue and West Nile viruses. J. Virol. 2007, 81, 4881-4885. 
45.  Harrison, S.C. The pH sensor for flavivirus membrane fusion. J. Cell Biol. 2008, 183, 177-179. 
46.  Stiasny, K.; Fritz, R.; Pangerl, K.; Heinz, F.X. Molecular mechanisms of flavivirus membrane 
fusion. Amino Acids 2009. doi: 10.1007/s00726-009-0370-4. Viruses 2011, 3                                       
 
 
169
47.  Fritz, R.; Stiasny, K.; Heinz, F.X. Identification of specific histidines as pH sensors in flavivirus 
membrane fusion. J. Cell Biol. 2008, 183, 353-361. 
48.  Nelson, S.; Poddar, S.; Lin, T.Y.; Pierson, T.C. Protonation of individual histidine residues is not 
required for the pH-dependent entry of west nile virus: evaluation of the "histidine switch" 
hypothesis. J. Virol. 2009, 83, 12631-12635. 
49.  Mukhopadhyay, S.; Kuhn, R.J.; Rossmann, M.G. A structural perspective of the flavivirus life 
cycle. Nat. Rev. Microbiol. 2005, 3, 13-22. 
50.  Liao, M.; Sanchez-San, M.C.; Zheng, A.; Kielian, M. In vitro reconstitution reveals key 
intermediate states of trimer formation by the dengue virus membrane fusion protein. J. Virol. 
2010, 84, 5730-5740. 
51.  Corver, J.; Ortiz, A.; Allison, S.L.; Schalich, J.; Heinz, F.X.; Wilschut, J. Membrane fusion 
activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model 
system. Virology 2000, 269, 37-46. 
52.  Gollins, S.W.; Porterfield, J.S. pH-dependent fusion between the flavivirus West Nile and 
liposomal model membranes. J. Gen. Virol. 1986, 67, 157-166. 
53.  Moesker, B.; Rodenhuis-Zybert, I.A.; Meijerhof, T.; Wilschut, J.; Smit, J.M. Characterization of 
the functional requirements of West Nile virus membrane fusion. J. Gen. Virol.  2010,  91,  
389-393. 
54.  Stiasny, K.; Koessl, C.; Heinz, F.X. Involvement of lipids in different steps of the flavivirus 
fusion mechanism. J. Virol. 2003, 77, 7856-7862. 
55.  Umashankar, M.; Sanchez-San, M.C.; Liao, M.; Reilly, B.; Guo, A.; Taylor, G.; Kielian, M. 
Differential cholesterol binding by class II fusion proteins determines membrane fusion 
properties. J. Virol. 2008, 82, 9245-9253. 
56.  Poh, M.K.; Yip, A.; Zhang, S.; Priestle, J.P.; Ma, N.L.; Smit, J.M.; Wilschut, J.; Shi, P.Y.; Wenk, 
M.R.; Schul, W. A small molecule fusion inhibitor of dengue virus. Antiviral Res. 2009, 84,  
260-266. 
57.  Schmidt, A.G.; Yang, P.L.; Harrison, S.C. Peptide inhibitors of dengue-virus entry target a late-
stage fusion intermediate. PLoS. Pathog. 2010, 6, e1000851. 
58.  Yu, I.M.; Holdaway, H.A.; Chipman, P.R.; Kuhn, R.J.; Rossmann, M.G.; Chen, J. Association of 
the pr peptides with dengue virus at acidic pH blocks membrane fusion. J. Virol.  2009,  83,  
12101-12107. 
59.  Das, S.; Chakraborty, S.; Basu, A. Critical role of lipid rafts in virus entry and activation of 
phosphoinositide 3' kinase/Akt signaling during early stages of Japanese encephalitis virus 
infection in neural stem/progenitor cells. J. Neurochem. 2010, 115, 537-549. 
60.  Puerta-Guardo, H.; Mosso, C.; Medina, F.; Liprandi, F.; Ludert, J.E.; del Angel, R.M. Antibody-
dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich 
membrane microdomains. J. Gen. Virol. 2010, 91, 394-403. 
61.  Tani, H.; Shiokawa, M.; Kaname, Y.; Kambara, H.; Mori, Y.; Abe, T.; Moriishi, K.; Matsuura, Y. 
Involvement of ceramide in the propagation of Japanese encephalitis virus. J. Virol. 2010, 84, 
2798-2807. 
62.  Schlegel, R.; Tralka, T.S.; Willingham, M.C.; Pastan, I. Inhibition of VSV binding and infectivity 
by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 1983, 32, 639-646. Viruses 2011, 3                                       
 
 
170
63.  Coil, D.A.; Miller, A.D. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis 
virus. J. Virol. 2004, 78, 10920-10926. 
64.  Stegmann, T.; Hoekstra, D.; Scherphof, G.; Wilschut, J. Kinetics of pH-dependent fusion between 
influenza virus and liposomes. Biochemistry 1985, 24, 3107-3113. 
65.  Stegmann, T.; Hoekstra, D.; Scherphof, G.; Wilschut, J. Fusion activity of influenza virus. A 
comparison between biological and artificial target membrane vesicles. J. Biol. Chem. 1986, 261, 
10966-10969. 
66.  Stegmann, T.; Nir, S.; Wilschut, J. Membrane fusion activity of influenza virus. Effects of 
gangliosides and negatively charged phospholipids in target liposomes. Biochemistry 1989, 28, 
1698-1704. 
67.  Stegmann, T.; Booy, F.P.; Wilschut, J. Effects of low pH on influenza virus. Activation and 
inactivation of the membrane fusion capacity of the hemagglutinin. J. Biol. Chem. 1987, 262, 
17744-17749. 
68.  Driessen, A.J.; Hoekstra, D.; Scherphof, G.; Kalicharan, R.D.; Wilschut, J. Low pH-induced 
fusion of liposomes with membrane vesicles derived from Bacillus subtilis. J. Biol. Chem. 1985, 
260, 10880-10887. 
69.  Anderson, R.; Wang, S.; Osiowy, C.; Issekutz, A.C. Activation of endothelial cells via antibody-
enhanced dengue virus infection of peripheral blood monocytes. J. Virol. 1997, 71, 4226-4232. 
70.  Cherrier, M.V.; Kaufmann, B.; Nybakken, G.E.; Lok, S.M.; Warren, J.T.; Chen, B.R.; Nelson, 
C.A.; Kostyuchenko, V.A.; Holdaway, H.A.; Chipman, P.R.; et al. Structural basis for the 
preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J. 2009, 28, 
3269-3276. 
71.  He, R.T.; Innis, B.L.; Nisalak, A.; Usawattanakul, W.; Wang, S.; Kalayanarooj, S.; Anderson, R. 
Antibodies that block virus attachment to Vero cells are a major component of the human 
neutralizing antibody response against dengue virus type 2. J. Med. Virol. 1995, 45, 451-461. 
72.  Putnak, R.; Cassidy, K.; Conforti, N.; Lee, R.; Sollazzo, D.; Truong, T.; Ing, E.; Dubois, D.; 
Sparkuhl, J.; Gastle, W.; et al. Immunogenic and protective response in mice immunized with a 
purified, inactivated, Dengue-2 virus vaccine prototype made in fetal rhesus lung cells. Am. J. 
Trop. Med. Hyg. 1996, 55, 504-510. 
73.  Se-Thoe, S.Y.; Ng, M.M.; Ling, A.E. Retrospective study of Western blot profiles in immune sera 
of natural dengue virus infections. J. Med. Virol. 1999, 57, 322-330. 
74.  Zybert, I.A.; van der Ende-Metselaar, H.H.; Wilschut, J.; Smit, J.M. Functional importance of 
dengue virus maturation: infectious properties of immature virions. J. Gen. Virol.  2008,  89,  
3047-3051. 
75.  Randolph, V.B.; Winkler, G.; Stollar, V. Acidotropic amines inhibit proteolytic processing of 
flavivirus prM protein. Virology 1990, 174, 450-458. 
76.  Heinz, F.X.; Stiasny, K.; Puschner-Auer, G.; Holzmann, H.; Allison, S.L.; Mandl, C.W.; Kunz, C. 
Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by 
the heterodimeric association with protein prM. Virology 1994, 198, 109-117. 
77.  Junjhon, J.; Edwards, T.J.; Utaipat, U.; Bowman, V.D.; Holdaway, H.A.; Zhang, W.; Keelapang, 
P.; Puttikhunt, C.; Perera, R.; Chipman, P.R.; et al. Influence of pr-M cleavage on the 
heterogeneity of extracellular dengue virus particles. J. Virol. 2010, 84, 8353-8358. Viruses 2011, 3                                       
 
 
171
78.  Deubel, V.; Digoutte, J.P.; Mattei, X.; Pandare, D. Morphogenesis of yellow fever virus in Aedes 
aegypti cultured cells. II. An ultrastructural study. Am. J. Trop. Med. Hyg. 1981, 30, 1071-1077. 
79.  Hase, T.; Summers, P.L.; Eckels, K.H.; Baze, W.B. An electron and immunoelectron microscopic 
study of dengue-2 virus infection of cultured mosquito cells: maturation events. Arch. Virol. 1987, 
92, 273-291. 
80.  Mackenzie, J.M.; Westaway, E.G. Assembly and maturation of the flavivirus Kunjin virus appear 
to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively.   
J. Virol. 2001, 75, 10787-10799. 
81.  Ng, M.L. Ultrastructural studies of Kunjin virus-infected Aedes albopictus cells. J. Gen. Virol. 
1987, 68, 577-582. 
82.  Welsch, S.; Miller, S.; Romero-Brey, I.; Merz, A.; Bleck, C.K.; Walther, P.; Fuller, S.D.; Antony, 
C.; Krijnse-Locker, J.; Bartenschlager, R. Composition and three-dimensional architecture of the 
dengue virus replication and assembly sites. Cell Host. Microbe 2009, 5, 365-375. 
83.  Yu, I.M.; Holdaway, H.A.; Chipman, P.R.; Kuhn, R.J.; Rossmann, M.G.; Chen, J. Structure of the 
immature dengue virus at low pH primes proteolytic maturation. J. Virol. 2009, 83, 12101-12107. 
84.  Wengler, G.; Wengler, G. Cell-associated West Nile flavivirus is covered with E+pre-M protein 
heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release.  
J. Virol. 1989, 63, 2521-2526. 
85.  Zheng, A.; Umashankar, M.; Kielian, M. In vitro and in vivo studies identify important features of 
dengue virus pr-E protein interactions. PLoS. Pathog. 2010, 6, e1001157. 
86.  Stadler, K.; Allison, S.L.; Schalich, J.; Heinz, F.X. Proteolytic activation of tick-borne 
encephalitis virus by furin. J. Virol. 1997, 71, 8475-8481. 
87.  Dejnirattisai, W.; Jumnainsong, A.; Onsirisakul, N.; Fitton, P.; Vasanawathana, S.; Limpitikul, 
W.; Puttikhunt, C.; Edwards, C.; Duangchinda, T.; Supasa, S.; et al. Cross-reacting antibodies 
enhance dengue virus infection in humans. Science 2010, 328, 745-748. 
88.  Rodenhuis-Zybert, I.A.; van der Schaar, H.M.; da Silva Voorham, J.; van der Ende-Metselaar, H.; 
Lei, H.Y.; Wilschut, J.;Smit, J.M. Immature dengue virus: a veiled pathogen? PLoS. Pathog. 
2010, 6, e1000718. 
89.  Junjhon, J.; Lausumpao, M.; Supasa, S.; Noisakran, S.; Songjaeng, A.; Saraithong, P.; Chaichoun, 
K.; Utaipat, U.; Keelapang, P.; Kanjanahaluethai, A.; et al. Differential modulation of prM 
cleavage, extracellular particle distribution, and virus infectivity by conserved residues at 
nonfurin consensus positions of the dengue virus pr-M junction. J. Virol. 2008, 82, 10776-10791. 
90.  Nelson, S.; Jost, C.A.; Xu, Q.; Ess, J.; Martin, J.E.; Oliphant, T.; Whitehead, S.S.; Durbin, A.P.; 
Graham, B.S.; Diamond, M.S.; et al. Maturation of West Nile virus modulates sensitivity to 
antibody-mediated neutralization. PLoS. Pathog. 2008, 4, e1000060. 
 
© 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
 
 